Trial no.:
|
PACTR202312820804233 |
Date of Approval:
|
14/12/2023 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Comparative study of efficacy and safety of tranexamic acid versus ethamsylate on Caesarean section blood loss at Federal Medical Centre, Owo: randomized controlled trial |
Official scientific title |
Comparative study of efficacy and safety of tranexamic acid versus ethamsylate on Caesarean section blood loss at Federal Medical Centre, Owo: randomized controlled trial |
Brief summary describing the background
and objectives of the trial
|
Caesarean section is becoming more popular and acceptable in developing countries. Postpartum haemorrhage is one of the commonest complications of Caesarean section despite the use of oxytocics. The use of haemostatic agents may be of benefit in further reducing this risk.
The objectives are;
To determine the efficacy and safety of Tranexamic acid versus Ethamsylate on blood loss in women undergoing Caesarean section at Federal Medical Centre, Owo.
To determine and compare the effect of tranexamic acid versus ethamsylate on the amount of blood loss during Caesarean section.
To determine and compare the change in haemoglobin level after Caesarean section following administration of tranexamic acid versus ethamsylate.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/12/2023 |
Actual trial start date |
|
Anticipated date of last follow up |
30/04/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
64 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|